FDA Office of Women's Health
This article was originally published in The Gray Sheet
Executive SummaryAn upcoming Federal Register notice will announce the establishment of the Office of Women's Health within the Office of External Affairs. The office will serve as "the principal advisor to the Commissioner and other key officials on scientific, ethical and policy issues relating to women's health," a statement of organization says. The office also will monitor "the inclusion of women in clinical trials and the implementation of guidelines concerning the representation of women in clinical trials and the completion of gender analysis." FDA's device center is developing a report on women in device studies
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.